Clinical and electroneuromyographic characterization of patients diagnosed with Guillain-Barré syndrome

Authors

Keywords:

Guillain-Barré Syndrome/diagnosis; electrophysiologie; neural conduction; reflex abnormal; muscle hypotonia; demyelinating diseases

Abstract

Introduction: Guillain-Barré syndrome is an immune-mediated acquired polyneuropathy. Electrodiagnostic studies define the type of affected fiber: motor or sensory. They are the main tool for establishing whether it is a demyelinating or axonal polyneuropathy. Objective: To characterize Guillain-Barré syndrome clinically and by electroneuromyography. Methods: Descriptive cross-sectional study from January one, 2022 to November 30, 2025, with a total population of 21 patients. The variables were age, sex, year of diagnosis, season of the year, history of infectious process, findings on neurological examination, electroneuromyographic diagnostic criteria, electrophysiological variants, and pathophysiological characteristics. Results: A total of 33.33 % of cases were older than 60 years, and 47.62 % were diagnosed in 2022. A total of 52.38 % had a history of recent arbovirus infection and 23.81 % of COVID-19. The predominant symptom was decreased muscle strength in 100 %. The most affected nerves were both tibial nerves, with prolongation of distal latencies in all patients. Conclusions: Nerve conduction studies and electroneuromyography constitute an indispensable examination in the management of Guillain-Barré syndrome because they complement the differential diagnosis, classification, and detection of possible sequelae in peripheral nerves. Motor clinical findings predominate in the lower limbs, associated with axonal damage with prolongation of distal latencies and reduced potential amplitude.

Downloads

Download data is not yet available.

Author Biographies

Judith Cabrera González , Leopoldito Martínez General Teaching Hospital. Faculty of Medical Sciences of Mayabeque.

Second-Degree Specialist in Normal and Pathological Physiology. Associate Professor and Associate Researcher. Leopoldito Martínez General Teaching Hospital. Faculty of Medical Sciences of Mayabeque. San José de las Lajas, Cuba.

Shaúl Bauzá González, Faculty of Medical Sciences of Mayabeque. Güines

Medical student. Faculty of Medical Sciences of Mayabeque, Mayabeque, Cuba.

Melissa Madely Rivero Viol, Neuroscience Center. Victoria de Girón Institute of Basic and Preclinical Sciences.

General Practitioner. Resident in Clinical Neurophysiology. Victoria de Giron Institute of Basic and Preclinical Sciences. Victoria de Girón. Havana, Cuba.

Elianet Viera Espinosa, Leopoldito Martínez General Teaching Hospital. Faculty of Medical Sciences of Mayabeque

First-Degree Specialist in Neurology. Leopoldito Martínez General Teaching Hospital, San José de las Lajas, Mayabeque, Cuba.

References

1.Cedeño Laz JA. Aspectos clínicos y epidemiológicos del síndrome de Guillain-Barré. Rev cuba med mil [Internet]. 2024 [citado 15 Nov 2025]; 53(2):e29684. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_abstract&pid=S0138-65572024000200043&lng=en&nrm=i&tlng=es

2.Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barré syndrome. The Lancet. 2021; 397(10280): 1214-28. doi: https://doi.org/10.1016/S0140-6736(21)00517-1

3.Gutiérrez López C, Plascencia Álvarez NI, Quiñones Aguilar S, Venegas Torres A, Núñez Orozco L. Síndrome de Guillain-Barré como manifestación paraneoplásica de linfoma no Hodgkin: reporte de un caso. Rev Mexicana Neuroci [Internet]. 2008 [citado 24 Ene 2026]; 9(3):239-41. Disponible en: https://previous.revmexneurociencia.com/articulo/sindrome-de-guillain-barre-como-manifestacion-paraneoplasica-de-linfoma-hodgkin-reporte-de-caso/

4.Donoso Noroña FR, Gómez Martínez N, Rodríguez Plasencia A, Toranzo Collado Z. Comportamiento del síndrome de Guillain-Barré. Un análisis controversial. Rev Inf Cient [Internet]. 2024 [citado 2 Ago 2025]; 103(suppl 1):e4386. Disponible en: https://revinfcientifica.sld.cu/index.php/ric/article/view/4386

5.Expósito J, Carrera L, Natera D, Nolasco G, Nascimento A, Ortez C. Síndrome de Guillain-Barré y otras neuropatías autoinmunes: tratamiento actual. Medicina (B. Aires) [Internet]. 2022 [citado 9 Nov 2025]; 82(suppl 3): 82-8. Disponible en: https://www.medicinabuenosaires.com/revistas/vol82-22/s3/82s3.pdf

6.Arends S, Drenthen J, de Koning L, van den Bergh P, Hadden RDM, Kuwabara S, et al. Electrodiagnostic subtyping in Guillain-Barré syndrome patients in the International Guillain-Barré Outcome Study. Eur J Neurol. 2024;31(9):e16335. doi: https://doi.org/10.1111/ene.16335

7.Leonhard SE, Mandarakas MR, Aquino Gondim FDA, Bateman K, Brito ML, Cornblath DR, et al. Guía basada en la evidencia. Diagnóstico y manejo del síndrome de Guillain-Barré en diez pasos. Medicina (B. Aires) [Internet]. 2021 [citado 8 Nov 2025];81(5):817-36. Disponible en:https://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802021000500817&lng=es

8.Mamani Alave MA. Técnicas de fisioterapia aplicables en las fases de Guillain Barre. Estudios [Internet]. 2022 [citado 8 Ene 2026];3(1):57-66. Disponible en: https://www.uab.edu.bo/ojs/index.php/fcdm/article/download/191/157

9.Alvarado J, Vergara L. Estudio electrodiagnóstico en síndrome de Guillain-Barré en adultos. Rev Chilena Neuro-psiquiatr. 2016;54(2):123-32. doi: https://dx.doi.org/10.4067/S0717-92272016000200006

10.Mani AM, Prabhakar AT, Alexander PT, Nair A, Vijayaraghavan A, Shaikh A, et al. Utility of serial nerve conduction studies in the electrodiagnosis of Guillain-Barre syndrome. Neurol India. 2021 Feb 12;69(2):369-75. doi: https://doi.org/10.4103/0028-3886.314529

11.Hernández Hernández A. Evolución electrofisológica de un grupo de pacientes con polineuropatíadesmielinizante inflamatoria crónica primaria y secundaria. Rev Cubana Inv Bioméd [Internet]. 2008 [citado 20 Ene 2026]; 27 (1): [aprox. 11p.]: Disponible en:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03002008000100007&lng=es

12.World Medical Association. Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Participants. JAMA. 2024; 23(18): e21972. doi: https://doi.org/10.1001/jama.2024.21972

13.Elundu C, Osamuyi EI, Afolayan IA, Opara NC, Chinedu-Anunaso NA, Okoro CB, et al. Clinical presentation and symptomatology of Guillain-Barré syndrome: a literature review. Medicine(Baltimore). 2024; 103(30):e38890. doi: https://doi.org/10.1097/MD.0000000000038890

14.Guo F, Yao QY, Wu XH, Guo HV, Su XL, Zhou JF, et al. Clinical characteristics of Guillain-Barré syndrome in Shenzhen: a retrospective study. BMC Neurol [Internet]. 2025 [citado 11 Ene 2026]; 25:72. Disponible en: https://pubmed.ncbi.nlm.nih.gov/39984908/

15.Oshomoji OI, Oti IK, Ajiroba JO, Semudara SO. Gender differences in Guillain-Barré syndrome presentations and outcomes: a systematic review. Bull Fac Phys Ther. 2025; 30:14. doi: https://doi.org/10.1186/s43161-025-00272-4

16.Mc Combe PA, Hardy TA, Nona RJ, Greer JM. Sex differences in Guillain-Barré syndrome, chronic inflammatory demyelinating polyradiculoneuropathy and experimental autoimmune neurities. Front Immunol. 2022; 13:1038411. doi: https://doi.org/10.3389/fimmu.2022.1038411

17.Lupu VV, Miron I, Cianga AL, Gavrilovici C, Grigore I, David AG, et al. Diagnostic pitfalls in Guillain-Barré syndrome: case report and litrature review. Children. 2022; 9(12):1969. doi: https://doi.org/10.3390/children9121969

18.Pampa Espinoza L, Mendoza Farro N, Espinoza Venegas L, Flores León D, Quino W, Gavilán RG, et al. Características clínicas y laboratoriales de los diez primeros pacientes con diagnóstico de Guillain-Barré en Piura, 2023. An Fac med. 2023;84(4):441-7. doi: https://dx.doi.org/10.15381/anales.v84i4.26202

19.Sreelakshmi V, Pattanaik A, Marate S, Mani RS, Pai AR, Mukhopadhyay C. Guillain-barré syndrome (GBS) with antecedents chikungunya infection: a case report and literature review. Neurol Res Pract. 2024; 6(21):1-11. doi: https://doi.org/10.1186/s42466-024-00315-6

20.Gordon PH, Wilbourn AJ. Early electrodiagnostic findings in Guillain-Barré syndrome. JAMA. 2001; 58(6): 913-7. doi: https://doi.org/10.1001/archneur.58.6.913

21.Liu S, Chu H, Peng B, Zeng Y, Liu J, Lu Z, et al. Clinical and electrophysiological features of pure sensory Guillain-Barré syndrome: retrospective analysis in 22 patients across 14 provinces in Southern China. BMC Neurol. 2025; 25(87):1-8. doi: https://doi.org/10.1186/s12883-025-04103-w

22.Khedr EM, Shehab MM, Mohamed MZ, Mohamed KO. Early elctrophysiological study variants and their relationship with clinical presentation and outcomes of patients with Guillain-Barré syndrome. Scientific Report. 2023; 13(14000):1-9. doi: https://doi.org/10.1038/s41598-023-41072-x

23.van Doorn PA, Van den Bergh PYK, Hadden RDM, Avau B, Vankrunkelsven P, Attarian S, et al. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of guillain-Barré syndrome. J Peripher Nerv Syst. 2023; 28(4): 536-63. doi: https://doi.org/10.1111/jns.12594

24.Geetanjali S, Sushma S, Sudhir S. Early electrodiagnostic findings irGuillain Barre syndrome. J Neurol Neurophysiol [Internet]. 2013 [citado 11 Ene 2026]; 4 (1): 1000142. Disponible en: https://www.iomcworld.org/open-access/early-electrodiagnostic-findings-of-guillain-barre-syndrome-2155-9562.1000142.pdf

25.Ayaz ul Haq M, Samin Y, Durrani T, Nabi D, Khan MO, Khan MA. Clinical and demographic characterictics of Guillain-Barré syndrome (GBS) variants in a Teritiary Care Hospital. Professional Med J. 2023;30(7):851-5. doi: https://doi.org/10.29309/TPMJ/2023.30.07.7494

26.Shamim F, Bano S, waqar M, Numn A. Guillain-Barre syndrome, clinical spectrum and electrophysiological subtypes: a local experience. J Shalamar Med Dent Coll. 2023;4(1):61-6. doi: https://doi.org/10.53685/jshmdc.v4i1.150

27.Berciano J. Patología axonal en la fase precoz del síndrome de Guillain-Barré. Neurología [Internet]. 2022 [citado 12 Nov 2025]; 37(6):421-512. Disponible en: https://www.elsevier.es/es-revista-neurologia-295-articulo-patologia-axonal-fase-precoz-del-S0213485318301762

28.Bellanti R, Rinaldi S. Guillain-Barré syndrome: a comprehensive review. Euro J Neurol. 2024;31(8):e16365. doi: https://doi.org/10.1111/ene.16365

Published

2026-11-16

How to Cite

1.
Cabrera González J, Bauzá González S, Rivero Viol MM, Viera Espinosa E. Clinical and electroneuromyographic characterization of patients diagnosed with Guillain-Barré syndrome. Medimay [Internet]. 2026 Nov. 16 [cited 2026 Nov. 17];33:e2873. Available from: https://medimay.sld.cu/index.php/rcmh/article/view/2873

Issue

Section

ORIGINAL ARTICLES